Similar articles

• Was [¹⁸F]fluorodeoxyglucose positron emission tomography complete response after chemoradiotherapy defined as standardized uptake value(max-1 hour) ≤ 3 complete?

  Ma W, Wang J, Yang W, Li G, Wang S. Ma W, et al. J Clin Oncol. 2011 Mar 20;29(9):e248; author reply e249-50. doi: 10.1200/JCO.2010.33.3989. Epub 2011 Jan 31. J Clin Oncol. 2011. PMID: 21282534 No abstract available.
• Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

  Kim MK, Ryu JS, Kim SB, Ahn JH, Kim SY, Park SI, Kim YH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Cho KJ, Kim JH. Kim MK, et al. Eur J Cancer. 2007 Jun;43(9):1385-91. doi: 10.1016/j.ejca.2007.04.001. Epub 2007 May 23. Eur J Cancer. 2007. PMID: 17512192 Clinical Trial.
• Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.

  Chen YM, Pan XF, Tong LJ, Shi YP, Chen T. Chen YM, et al. Nucl Med Commun. 2011 Nov;32(11):1005-10. doi: 10.1097/MNM.0b013e32834a8366. Nucl Med Commun. 2011. PMID: 21886014
• The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

  Chowdhury FU, Bradley KM, Gleeson FV. Chowdhury FU, et al. Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21. Clin Radiol. 2008. PMID: 18996259 Review.
• The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.

  Bombardieri E. Bombardieri E. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):753-8. doi: 10.1007/s00259-006-0147-x. Eur J Nucl Med Mol Imaging. 2006. PMID: 16733687 Review. No abstract available.